why choose us
99%
Timely Delivery
24/7
Online Support
99%
Positive Customer Feedback
SKUs
1.2 Million Products
Latest News
KRISHGEN, today announced that, as on July 11, 2019, it entered into a License and Commercialization Agreement with life sciences and reagents manufacturer, KinesisDx, USA, which provides Krishgen with worldwide distribution, development and commercialization rights to KinesisDx's product line for use in research life sciences and clinical markets for undisclosed amount.
Krishgen will be the exclusive worldwide distributor of KinesisDx p
KRISHGEN successfully offers its new glycosylation range of products including PNGase F enzyme for de-glycosylation, 2AB Labelling Kits and Glycan Standards under the KRISHZYME brand.
KRISHGEN has successfully developed and achieved CE certification for its Biomonitoring Kits for Therapeutic Mabs. This enables the kits to be marked as IVD. These include ELISA kits for Rituximab, Adalimumab, Trastuzumab, Eculizumab, Cetuximab amongst others.
The uniqueness of these kits is the high degree of validation including correlation to the innovator / reference drugs available in the market. Each assay for measurement of the dr
Upcoming Events
Featured Products
Latest Products
Enquire
Testimonials
WE ALSO DISTRIBUTE SPECIFICALLY IN ASIA INCL. INDIA FOR
